Sustained Complete Response to First-Line Immunochemotherapy for Highly Aggressive TP53/MDM2-mutated Upper Tract Urothelial Carcinoma with ERBB2 Mutations, Luminal Immune-Infiltrated Contexture, and Non-Mesenchymal State: a Case Report and Literature Review
FRONTIERS IN ONCOLOGY（2023）
关键词
upper tract urothelial carcinoma,immunochemotherapy,TP53,MDM2,ErbB2,luminal-infiltrated,circulating tumor DNA (ctDNA),case report,sintilimab
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要